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Abstract Using an in vivo assay system, nuclear import ability
in individual cells was determined by examining the nuclear
import rate. It was found that when a small (not excess) amount
of SV40 T-NLS peptides was co-injected, the nuclear import rate
of SV40 T-NLS-containing substrates apparently increased. This
up-regulation was reproduced by the co-injection of peptides
containing bipartite type NLS of CBP80, but not mutated non-
functional NLS peptides, which suggests that these phenomena
are specific for functional NLSs. It was further shown that
although, in growth-arrested cells, the nuclear import rate was
down-regulated compared to growing cells, the elevation of the
functional import rate by co-injected NLS peptides reached the
same level as in proliferating cells. This up-regulation was
abolished by the addition of a protein kinase inhibitor,
staurosporine. These results suggest that although potential
nuclear import ability does not vary in each cell, the rate of
nuclear import may be controlled by the amount of karyophilic
proteins, which need to be carried into the nucleus from the
cytoplasm, possibly via an NLS-dependent phosphorylation
reaction.
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Key words: Nuclear protein import; Nuclear localization
signal; Phosphorylation
1. Introduction
Nuclear protein import, which occurs through the nuclear
pore complex, requires energy and soluble factors, and is
mediated by the nuclear localization sequence (NLS) [1,2]. A
characteristic feature of the NLS is a basic amino acid cluster
in the primary amino acid sequence of the karyophilic pro-
teins, although there might be no obvious consensus se-
quences. It has been proposed that the conventional NLSs
can be divided into two groups: (1) single basic type (for
example, the SV40 T-antigen) and (2) bipartite basic type
(such as nucleoplasmin and Cap-binding protein, CBP80).
Recently, soluble factors required for nuclear protein im-
port have been identi¢ed and characterized, mainly via the use
of an in vitro import assay with digitonin-permeabilized semi-
intact cells [3]. It is a well-known fact that NLS triggers the
formation of a stable complex in the cytoplasm, which is
termed the nuclear pore-targeting complex (PTAC) [4]. Two
essential components which are involved in complex forma-
tion are referred to as PTAC58/PTAC97, importin-K/impor-
tin-L, karyopherin-K/karyopherin-L, and the NLS receptor/
p97 [5^14]. This complex, including a karyophile, binds to
the nuclear pore via importin-L, and the karyophile is then
translocated into the nucleus, with the support of a small G
protein, Ran [15,16], and Ran-interacting protein, p10/NTF2
[17,18]. In addition, several additional factors, which regulate
the Ran GTPase cycle, also have been shown to be directly or
indirectly involved in nuclear protein import [19].
It has also been shown that the intracellular behavior of
some karyophilic proteins is regulated by the cell cycle or
an extracellular signal. The nuclear accumulation of viral
Jun (v-Jun) was found to be cell cycle-dependent, and this
dependence is regulated by the phosphorylation of a serine
residue which is located close to the NLS [20]. A transcription
factor SWI5 is located in the cytoplasm when it is phosphoryl-
ated near its NLS in the G2 and M phase, but is translocated
into the nucleus after dephosphorylation in the G1 phase [21].
In contrast, a transcription factor, NF-UB, does not enter the
nucleus until its cytoplasmic anchoring protein, IUB, is phos-
phorylated and released from NF-UB after some extracellular
stimuli [22]. In response to interferon-Q, a transcription factor,
Stat1, is phosphorylated by the Jak family of tyrosine kinases,
and then is translocated into the nucleus and directly activates
target genes [23]. Recently, it was demonstrated that the in-
terferon-Q-dependent nuclear import of Stat1 also requires
Ran and the formation of PTAC with NPI-1, but not Rch1
of the importin-K family [24,25].
As described above, although our understanding of the
mechanism of karyophilic protein-speci¢c control is now in-
creasing at the molecular level, little is known about whether
or how the import machinery itself is regulated. It has previ-
ously been demonstrated that proliferating cells have a higher
import e⁄ciency than serum-starved growth-arrested cells
[26]. In addition, in the course of an in vivo study of p10/
NTF2, we recently reported that the injection of p10/NTF2
inhibits the nuclear import of co-injected NLS substrates in a
dose-dependent manner. From these results, we speculated
that p10/NTF2 not only plays an essential role in nuclear
protein import, but also regulates nuclear transport e⁄ciency
in cells [27]. However, these regulatory mechanisms or com-
ponents have not yet been studied at the molecular level.
The present study describes some experiments which are
designed to better understand the molecular mechanisms
which control nuclear protein import. Using an in vivo assay
system, we found that when a small dose of SV40 T-NLS
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peptides is co-injected with SV40 T-NLS-containing substrates
into the cytoplasm of living cells, the kinetics of nuclear im-
port were stimulated compared to the case when the sub-
strates alone were injected. The results herein suggest that
the ability of nuclear protein import can be up-regulated by
the amount of nuclear proteins which are present in the cyto-
plasm. The present study is directed toward the identi¢cation
of regulatory components which have not yet been identi¢ed
and to develop a better understanding of the regulation of
nuclear protein import.
2. Materials and methods
2.1. Cell culture and synchronization
Normal baby hamster kidney (BHK21) cells were cultured in 5%
CO2 at 37‡C in Dulbecco’s modi¢ed Eagle’s minimum essential
(DME) medium (Gibco BRL) supplemented with 5% fetal bovine
serum (Dainippon). For growth arrest, cells were cultured for 72 h
in minimum essential medium containing 0.5% serum.
2.2. Synthetic peptides
Synthetic peptides containing SV40 T-antigen wild type NLS
(CYGGPKKKRKVEDP), its reverse type NLS (CYGGPDEVKR-
KKKP) and CBP80 NLS (CYMSRRRHSDENDGGQPHKRRKTS-
DANETED) were purchased from the Peptide Institute (Osaka, Ja-
pan).
2.3. Preparation of NLS-conjugated protein
As a substrate for nuclear import assay, £uorescein isothiocyanate
(FITC)-labeled bovine serum albumin (BSA) was chemically conju-
gated to a synthetic peptide (CYGGPKKKRKVEDP) containing
NLS of SV40 T-antigen as described previously [28] (FITC-T-BSA).
Two types of FITC-T-BSA were prepared. The number of peptides
conjugated was estimated by mobility shift assays on SDS-polyacry-
lamide gels. The preparations had a large number (average 9^11) or a
small number (average 2^4) of peptides per BSA molecule.
2.4. Microinjection and quantitation of nuclear import kinetics
Cells were seeded on indexed glass coverslips. Materials were micro-
injected through a glass capillary into the cytoplasm of cells. Injected
cells were incubated for the indicated time at 37‡C prior to ¢xation
with formaldehyde. For quantitation of the nucleocytoplasmic ratio of
cytoplasmically injected FITC-T-BSA, after ¢xation with a time se-
quence, the cells were analyzed on a confocal LSM310 Laser Scan
Microscope system (Carl Zeiss). The £uorescence values of nuclear
and cytoplasmic areas in each cell were measured using MacSCOPE
software (Mitani Co.) and the nucleus/whole cell ratio was calculated.
Data are expressed as mean þ S.E.M. of values obtained from 40 cells
in two independent experiments (20 cells per experiment).
3. Results
3.1. An in vivo system for analyzing the kinetics of nuclear
protein import
We assumed that each cell has a unique ability with respect
to nuclear protein import and this ability would be expected
to vary in response to the extracellular environment or intra-
cellular conditions. In order to evaluate this ability, we at-
tempted to examine the rate of nuclear protein import for
each cell. In order to analyze the nuclear protein import ki-
netically, we initially prepared two types of transport sub-
strates, FITC-labeled BSA conjugated with a large number
(9^11 molecules per BSA) of SV40 T-NLS peptides or a small
number (2^4 molecules per BSA). After the £uorescent-la-
beled karyophiles were microinjected into the cytoplasm of
cultured mammalian (BHK) cells, the cells were incubated
for various periods of time and the nuclear accumulation of
injected substrates was quantitated as described in Section 2.
As shown in Fig. 1, when FITC-T-BSA containing a large
number of NLS peptides was injected into the cytoplasm,
more than 90% of the injected substrates accumulated in the
nucleus within 10 min and reached a plateau level. In contrast,
we found that FITC-T-BSA which contained a small number
of peptides was translocated relatively slowly into the nucleus
reaching a plateau state 20^30 min after cytoplasmic injection
(Fig. 1). Therefore, we concluded that the substrates which
contained a large number of NLSs are not suitable for kinetic
analysis because of the di⁄culty of following the detailed time
course of the import of proteins precisely just after microin-
jection. It was further con¢rmed that when injected into a
nucleus of a multinucleated homokaryon, the substrates which
contained a small number of NLS peptides did not migrate
from the injected nucleus to other nuclei within 1 h (data not
shown), meaning that the substrates injected into the cyto-
plasm do not shuttle back from the nucleus to the cytoplasm
within 1 h. Therefore, it was assumed that the import kinetics
can be evaluated precisely only if the data are collected within
30 min after the cytoplasmic injection. On the basis of these
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Fig. 1. Nuclear import kinetics of NLS-containing substrates. FITC-
T-BSA (15 WM) containing a large (b) or small (a) number of
SV40 T-NLS peptides was microinjected into the cytoplasm of
BHK cells. These cells were then incubated at 37‡C for the indi-
cated times prior to ¢xation. The nuclear import of injected sub-
strates was quantitated (see Section 2).
Fig. 2. The increase in nuclear import rate of NLS-containing sub-
strates is dependent on the amount of co-injected NLS peptides.
15 WM FITC-T-BSA was microinjected with the indicated concen-
tration of SV40 T-NLS peptides. These cells were then incubated at
37‡C for 20 min prior to ¢xation and nuclear import of FITC-T-
BSA was quantitated.
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results, for further in vivo analysis, we used FITC-T-BSA
containing a small number of NLS peptides.
3.2. Kinetics of nuclear import of NLS-containing substrates
are a¡ected by co-injection of free NLS peptides
It is known that NLS-mediated protein import is compet-
itively inhibited in the presence of an excess of NLS-contain-
ing protein or NLS peptides, which suggests that nuclear pro-
tein import is a saturable and receptor-mediated pathway.
Using our in vivo assay system, we examined whether it is
possible to titrate the saturability of a limiting number of
nuclear import components in each mammalian cell. FITC-
T-BSA (15 WM) was co-injected with various amounts of free
SV40 T-NLS peptides into the cytoplasm of cells. As shown in
Fig. 2, the co-injection of an excess (10 mM) of NLS peptides
caused suppression of the nuclear import of the FITC-T-BSA,
which is in agreement with a previous report [29]. However,
unexpectedly, it was found that co-injection of low concen-
trations (0.1^1 mM) of NLS peptides conversely increased the
rate of the nuclear import of the FITC-T-BSA. Because cyclo-
heximide was found not to a¡ect this phenomenon (data not
shown), new protein synthesis is not a prerequisite for the
increase of nuclear import rate.
When the concentration of NLS peptides was 0.5 mM, a
maximal e¡ect on the nuclear import was observed. There-
fore, we next examined the time course of nuclear import of
the FITC-T-BSA in the presence of 0.5 mM of NLS peptides.
The subcellular distribution view of microinjected FITC-T-
BSA is shown in Fig. 3A. In Fig. 3B, the nucleus/whole cell
ratio of the £uorescence is plotted as a function of time after
injection within 30 min. As shown in Fig. 3A,B, the nuclear
accumulation of the FITC-T-BSA reached a plateau within 10
min after injection. As a control experiment, co-injection of
NLS peptides with FITC-BSA had no e¡ect on the distribu-
tion of FITC-BSA (Fig. 3B). These ¢ndings suggest that the
co-injection of lower concentrations of NLS peptides than
required for the complete competition conversely stimulates
the kinetics of nuclear import.
3.3. Increase of nuclear import rate by other types of NLS
peptides
As described in Section 1, the conventional basic type of
NLS can be divided into two classes [30]. SV40 T-NLS (single
type)- and CBP80-NLS (bipartite type)-containing substrates
are both known to be transported into the nucleus via PTAC
formation [14,31]. Therefore, in order to understand whether
the up-regulation of the nuclear import rate of SV40 T-NLS-
containing substrates is limited to the same NLS peptides, we
examined the nuclear import of FITC-T-BSA when CBP80-
NLS peptides were co-injected. For experimental convenience,
we examined the nuclear import rate by analyzing the data at
20 min after injection. As shown in Fig. 4, the rate of nuclear
import of FITC-T-BSA was increased by the presence of
CBP80-NLS peptides to the same extent as T-NLS peptides.
Furthermore, as shown in Fig. 4, the co-injection of the non-
functional reverse type of NLS peptides of SV40 T-antigen
had no e¡ect on the nuclear import of FITC-T-BSA at all.
These results indicate that the up-regulation of the nuclear
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Fig. 3. Time course of nuclear import of NLS-containing substrates
in the presence of 0.5 mM NLS peptide. A: 15 WM FITC-T-BSA
was microinjected with bu¡er (control) or 0.5 mM SV40 T-NLS
peptide. Injected cells were incubated for the indicated times at
37‡C. The location of injected FITC-T-BSA is indicated. B: 15 WM
FITC-T-BSA (a, b) or 15 WM FITC-BSA (O, R) was microin-
jected with (b, R) or without (a, O) 0.5 mM SV40 T-NLS peptide.
Injected cells were incubated for the indicated times at 37‡C and nu-
clear import of injected substrates was quantitated.
Fig. 4. Co-injection of not only single type but also bipartite type
NLS peptides increases nuclear import e⁄ciency of NLS-containing
substrates. 15 WM FITC-T-BSA was microinjected with bu¡er, 0.5
mM SV40-T wild type NLS (wild T), its reverse type (reverse T),
CBP80 NLS peptides into the cytoplasm of cells. These cells were
then incubated at 37‡C for 20 min and nuclear import of FITC-T-
BSA was quantitated.
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import rate observed in this study is speci¢c to functional
NLS peptides of both the single and bipartite types.
3.4. E¡ect of co-injected NLS peptides on the nuclear import in
growth-arrested cells
It has been shown, using microinjection of nuclear protein-
coated colloidal gold, that the nuclear import e⁄ciency in
growth-arrested cells is lower than in proliferating cells [26].
To test whether the up-regulation of nuclear import as shown
in this report is related to cell growth, we examined the e¡ect
of the SV40 T-NLS peptides on the nuclear import rate in
growth-arrested cells. As shown in Fig. 5, in growth-arrested
cells, the nuclear import rate was signi¢cantly reduced com-
pared with that in non-arrested cells, which is consistent with
the previous report [26]. On the other hand, when free NLS
peptides (0.5 mM) were co-injected into the cytoplasm of
growth-arrested cells, the rate of nuclear accumulation of
FITC-T-BSA increased to the same level as that stimulated
in non-arrested cells. These results indicate that growth-ar-
rested cells have the same potential ability for nuclear import
as growing cells, although the functional import rate is down-
regulated in growth-arrested cells.
3.5. Up-regulation of the nuclear import rate by co-injection of
NLS peptides was suppressed by treatment of cells with a
protein kinase inhibitor
We speculated that the rapid response of the nuclear import
rate to the co-injected NLS peptides may be due to intracel-
lular protein modi¢cation, most likely protein phosphoryla-
tion. In order to demonstrate this hypothesis, we examined
whether the phosphorylation reaction is involved in the up-
regulation of nuclear import. FITC-T-BSA was microinjected
with or without SV40 T-NLS peptides into the cytoplasm 20
min after the cells were treated with staurosporine, a general
kinase inhibitor. As shown in Fig. 6, although the nuclear
import rate of FITC-T-BSA in the absence of free NLS pep-
tides was not a¡ected, the up-regulation of nuclear import
observed by co-injection of NLS peptides was suppressed by
staurosporine treatment. This ¢nding suggests that the up-
regulation of the nuclear import rate observed in the presence
of free NLS peptides may be mediated via a protein phos-
phorylation reaction.
4. Discussion
In order to understand the regulatory mechanism of nuclear
import, we focused on the rate of import as the index. Using
SV40 T-NLS substrates which contain a small number of
peptides, we were able to monitor the kinetics of transport
in living mammalian cells. Using this in vivo assay system, we
observed that the nuclear import of the SV40 T-NLS-contain-
ing substrate is kinetically stimulated by co-injection of
amounts of two types of NLS peptides at concentrations
less than required for complete inhibition, even though we
expected that the competition would be observed in a dose-
dependent manner. The stimulation was found to be speci¢c
for functional NLSs. These results indicate that the co-injec-
tion of the NLS peptides induces a stimulation in the rate of
nuclear protein import and that a regulatory system may well
exist that monitors and responds to an intracellular alteration
of the amount of karyophiles to be transported into the nu-
cleus.
Several possible explanations exist for the stimulation of the
nuclear import rate. First, regulatory factors, which have not
yet been identi¢ed, may elevate the e⁄ciency of NLS recog-
nition by importin-K or the formation of the nuclear pore-
targeting complex. One such candidate is a molecular chaper-
on such as hsc70. Although the exact role of hsc70 on nuclear
protein transport is not yet clear [32], it has been found that
elevated hsc70 levels suppress the nuclear import defects in a
yeast srp1/NLS receptor mutant [33], suggesting the possibil-
ity that a molecular chaperon may promote the formation and
stability of the nuclear pore-targeting complex. Second, the
recycling rate of transport factors such as importin-K and -L
may be stimulated, resulting in an apparent elevation of the
import rate. Third, a portion of the transport factors may be
routinely stored as inactive forms in a reservoir, for later
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Fig. 5. The increase in nuclear import e⁄ciency in the presence of
NLS peptide in growth-arrested cells. FITC-T-BSA was microin-
jected with bu¡er or 0.5 mM SV40 T-NLS peptides (wild T) into
the cytoplasm of non-arrested (left hand) or growth-arrested (right
hand) cells (see Section 2). These cells were then incubated at 37‡C
for 20 min and nuclear import of FITC-T-BSA was quantitated.
*P6 0.05 versus bu¡er control (Student’s t-test for unpaired data).
Fig. 6. Staurosporine, a protein kinase inhibitor, inhibits the in-
crease in nuclear import e⁄ciency by co-injected NLS peptides.
BHK cells were treated with (right) or without (left) 100 nM stauro-
sporine for 20 min. 15 WM FITC-T-BSA was then microinjected
with bu¡er or 0.5 mM SV40 T-NLS peptides (wild T). The cells
were then incubated at 37‡C for 20 min in the presence (right hand)
or absence (left hand) of staurosporine, and nuclear import of
FITC-T-BSA was quantitated. *P6 0.05 versus bu¡er control (Stu-
dent’s t-test for unpaired data).
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activation in response to cell activity. Fourth, other types of
transport factors which are ordinarily involved in di¡erent
transport pathways may be mobilized in response to some
type of NLS. Alternatively, the elevated function of the nu-
clear pore complex, such as the binding of higher concentra-
tions of SUMO-1-modi¢ed RanGAP1 to RanBP2, must be
considered [34]. Lastly, the movement of the targeting com-
plex from the cytoplasm to the nuclear pores may be facili-
tated in some manner, although how the complex moves in
the cytoplasm is currently unknown. Further studies will be
required to elucidate these or other possibilities.
In the cells cycling from the mitotic phase to interphase,
after complete reformation of the functional nuclear envelope,
an enormous number of nuclear proteins which are scattered
in the cytoplasm during mitotic phase must accumulate into
the nucleus. Therefore, it is suspected that the protein import
machinery may be activated in order for nuclear proteins to
be quickly and e⁄ciently imported into the nucleus just after
mitosis. In fact, it was previously reported that nuclear import
e⁄ciency is greatest at 1 h post anaphase during the cell cycle
[35]. In addition, it has been shown that the arrest of cell
growth leads to a decrease in nuclear import e⁄ciency [36].
Consistent with this report, as shown in Fig. 5, the rate of
nuclear protein import was found to be reduced in growth-
arrested cells, compared with growing cells. In contrast, the
stimulation of the rate of nuclear import induced by co-injec-
tion of NLS-peptides in the growth-arrested cells was the
same as that in the growing cells (Fig. 5), suggesting that
the potential ability of nuclear protein import in the
growth-arrested cells is nearly equivalent to that in the grow-
ing cells. In proliferating cells, much more nuclear proteins
may need to be constitutively transported into the nucleus
compared with those in quiescent cells. Therefore, the nuclear
import rate may be maintained at a higher level in proliferat-
ing cells compared with resting cells.
It has been shown that a co-injected protein kinase A in-
hibitor blocks the nuclear import of NLS-containing sub-
strates [37], and that while injected SV40-transformed cell ex-
tracts stimulate nuclear import, the e¡ect is abolished by a
protein kinase inhibitor or protein phosphatase [36]. More-
over, the above workers showed that the injection of various
protein kinases (PKA, PKC, MAPK, but not CK-I and II)
activates nuclear import. Recently, we identi¢ed a protein
kinase which is activated by NLS peptides [38]. In this study,
it was shown that the up-regulation of nuclear protein import
by co-injection of NLS peptides is suppressed by the treat-
ment of cells with a protein kinase inhibitor (Fig. 6). Although
the relationship between the phenomena investigated in this
report and the above mentioned kinases is not clear, the pos-
sibility of the existence of NLS-activated kinase(s) which up-
regulate nuclear protein import cannot be ignored. Such ki-
nase(s) may phosphorylate nuclear transport factors including
cytosolic factors such as the PTAC components or nuclear
pore complex protein. Alternatively, we previously showed
that the e⁄ciency of nuclear protein import is regulated by
the Ran-GTPase cycle via the use of tsBN2 cells which have a
mutation in the Ran GDP/GTP exchange factor gene, RCC1
[39]. It is possible that target molecules of NLS-dependent
kinase(s) may be Ran-regulating proteins such as RanGAP1
and RanBP1. The identi¢cation and characterization of such
kinase(s) and their target molecules would be expected to
contribute greatly to our understanding of the molecular
mechanism of the regulation of nuclear protein import.
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